Hemodynamic effects of iodixanol and iohexol during ventriculography in patients with compromised left ventricular function
Corresponding Author
Arend Bergstra BSC
Department of Cardiology/Thoraxcenter, Groningen University Hospital, Groningen, The Netherlands
Department of Cardiology/Thoraxcenter, University Hospital Groningen, PO Box 30.001, 9700 RB Groningen, The NetherlandsSearch for more papers by this authorRené B. van Dijk MD, PhD
Department of Cardiology, Martini Hospital, Groningen, The Netherlands
Search for more papers by this authorArie E. Buurma BSC
Department of Cardiology/Thoraxcenter, Groningen University Hospital, Groningen, The Netherlands
Search for more papers by this authorPeter den Heijer MD, PhD
Department of Cardiology, Ignatius Hospital, Breda, The Netherlands
Search for more papers by this authorHarry J.G.M. Crijns MD, PhD
Department of Cardiology/Thoraxcenter, Groningen University Hospital, Groningen, The Netherlands
Search for more papers by this authorCorresponding Author
Arend Bergstra BSC
Department of Cardiology/Thoraxcenter, Groningen University Hospital, Groningen, The Netherlands
Department of Cardiology/Thoraxcenter, University Hospital Groningen, PO Box 30.001, 9700 RB Groningen, The NetherlandsSearch for more papers by this authorRené B. van Dijk MD, PhD
Department of Cardiology, Martini Hospital, Groningen, The Netherlands
Search for more papers by this authorArie E. Buurma BSC
Department of Cardiology/Thoraxcenter, Groningen University Hospital, Groningen, The Netherlands
Search for more papers by this authorPeter den Heijer MD, PhD
Department of Cardiology, Ignatius Hospital, Breda, The Netherlands
Search for more papers by this authorHarry J.G.M. Crijns MD, PhD
Department of Cardiology/Thoraxcenter, Groningen University Hospital, Groningen, The Netherlands
Search for more papers by this authorAbstract
A crossover study was performed to compare the hemodynamic effects of the iso-osmolar contrast agent iodixanol (Visipaque®) 320 mg I/ml to those of the low-osmolar iohexol (Omnipaque®) 350 mg I/ml. The main hypothesis was that iodixanol and iohexol would affect left ventricular end-diastolic pressure (LVEDP) to different degrees. In 48 patients with reduced cardiac function (mean ejection fraction 33.4%), one ventricular injection was performed with each contrast medium. Ventricular, aortic and right atrial pressures and heart rate were measured continuously. Cardiac output (using Fick's principle) and systemic vascular resistance were calculated. LVEDP increased with both agents, but significantly less after iodixanol than after iohexol (P < 0.01), also in subgroups of patients in whom baseline LVEDP was severely increased and in whom 3-vessel disease was present. Immediate changes in variables reflecting vasodilatation were similar with both agents. In conclusion, both contrast agents influenced hemodynamics during ventriculography, but iodixanol had significantly less influence on LVEDP than did iohexol. Cathet. Cardiovasc. Intervent. 50:314–321, 2000. © 2000 Wiley-Liss, Inc.
REFERENCES
- 1 Dawson P. Cardiovascular effects of contrast agents. Am J Cardiol 1989; 64: 2E-9E.
- 2 Matthai WH, Hirshfeld JW. Choice of contrast agents for cardiac angiography: review and recommendations based on clinically important distinctions. Cathet Cardiovasc Diagn 1991; 22: 278–289.
- 3 Koeda T, Motegi I, Ichikawa T, Suzuki T, Kato M. Changes in hemodynamics due to contrast medium during left ventriculography. Angiology 1987; 38: 825–832.
- 4 Hirshfeld JW. Cardiovascular effects of iodinated contrast agents. Am J Cardiol 1990; 66: 9F–17F.
- 5 Lins M, Röhling D, Zahorsky R, Höfig M, Herrmann G, Simon R. Comparison of the non-ionic low osmolar (iomeprol 350) and ionic high osmolar (diatrizoat 370) contrast agent on hemodynamics during heart catheterization—a double-blind randomized study. Z Kardiol 1994; 83: 626–633.
- 6 Pedersen HK. Electrolyte addition to nonionic contrast media—cardiac effects during experimental coronary arteriography. Doctoral thesis. Acta Radiol 1996; 37(Suppl 405): 1–31.
- 7 Kinnison ML, Powe NR, Steinberg EP. Results of randomized controlled trials of low- versus high-osmolality contrast media. Radiology 1989; 170: 381–389.
- 8 Murdock CJ, Davis MJE, Ireland MA, Gibbons FA, Cope GD. Comparison of meglumine sodium diatrizoate, iopamidol, and iohexol for coronary angiography and ventriculography. Cathet Cardiovasc Diagn 1990; 19: 179–183.
- 9 Aguirre F, Pedersen W, Castello R, Deligonul U, Gudipati C, Serota H, Labovitz AJ, Kern MJ. The effects of high (sodium meglumine diatrizoate, Renografin-76) and low osmolar (sodium meglumine ioxaglate, Hexabrix) radiographic contrast media on diastolic function during left ventriculography in patients. Am Heart J 1991; 121: 848–857.
- 10 Vik-Mo H, Rosland GA, Følling M, Danielsen R. Hemodynamic and electrocardiographic consequences of high- and low-osmolality contrast agents for left ventricular angiography. Cathet Cardiovasc Diagn 1988; 14: 143–149.
- 11 Reagan K, Bettman MA, Finkelstein J, Ganz P, Grassi CJ. Double-blind study of a new nonionic contrast agent for cardiac angiography. Radiology 1988; 167: 409–413.
- 12 Hirshfeld JW, Wieland J, Davis CA, Giles BD, Passione D, Ray MB, Ripley NS. Hemodynamic and electrocardiographic effects of ioversol during cardiac angiography. Comparison with iopamidol and diatrizoate. Invest Radiol 1989; 24: 138–144.
- 13 Ritchie JL, Nissen SE, Douglas JS, Dreifus LS, Gibbons RJ, Higgins CB, Schelbert HR, Seward JB, Zaret BL. ACC position statement—use of nonionic or low osmolar contrast agents in cardiovascular procedures. JACC 1993; 21: 269–273.
- 14 Matthai WH, Kussmaul WG, Krol J, Goin JE, Schwartz JS, Hirshfeld JW. A comparison of low- with high-osmolality contrast agents in cardiac angiography. Identification of criteria for selective use. Circulation 1994; 89: 291–301.
- 15 Hill JA, Winniford M, Cohen MB, Van Fossen DB, Murphy MJ, Halpern EF, Ludbrook PA, Wexler L, Rudnick MR, Goldfarb S. Multicenter trial of ionic versus nonionic contrast media for cardiac angiography. Am J Cardiol 1993; 72: 770–775.
- 16 Barrett BJ, Parfrey PS, Vavasour HM, O'Dea F, Kent G, Stone E. A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization. N Engl J Med 1992; 326: 431–436.
- 17 Steinberg EP, Moore RD, Powe NR, Gopalan R, Davidoff AJ, Litt M, Graziano S, Brinker JA. Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography. N Engl J Med 1992; 326: 425–430.
- 18 Jynge P, Blankson H, Falck G, Refsum H, Karlsson JOG, Almén T, Øksendal AN. Sodium–calcium relationships and cardiac function during coronary bolus perfusion. Act Radiol 1995; 36(Suppl 399): 122–134.
- 19 Jynge P, Holten T, Øksendal AN. Sodium–calcium balance and cardiac function with isotonic iodixanol. An experimental study in the isolated rat heart. Invest Radiol 1993; 28: 20–25.
- 20 Kløw NE, Mortensen E, Refsum H. Left ventricular systolic and diastolic function during coronary arteriography before and after acute left ventricular failure in dogs. A comparison between iodixanol, iohexol and ioxaglate. Acta Radiol 1991; 32: 124–129.
- 21 Dundore RL, Silver PJ, Ezrin AM, Lee KC, Buchholz RA, Van Aller G, Clas DM, Roth GM, Harnish PP, Bailey DM, Pagani ED. The effects of iodixanol and iopamidol on hemodynamic and cardiac electrophysiologic parameters in vitro and in vivo. Invest Radiol 1991; 26: 715–721.
- 22 Dunkel JA, Bøkenes J, Karlsson JOG, Refsum H. Cardiac effects of iodixanol compared to those of other nonionic and ionic contrast media in the isolated rat heart. Acta Radiol 1995; 36(Suppl 399): 142–154.
- 23 Muschick P, Wehrmann D, Schuhmann-Giampieri G, Krause W. Cardiac and hemodynamic tolerability of iodinated contrast media in the anesthetized rat. Invest Radiol 1995; 30: 745–753.
- 24 Hill JA, Cohen MB, Kou WH, Mancini J, Mansour M, Fountaine H, Brinker JA. Iodixanol, a new isosmotic nonionic contrast agent compared with iohexol in cardiac angiography. Am J Cardiol 1994; 74: 57–63.
- 25 Kløw NE, Levorstad K, Berg KJ, Brodahl U, Endresen K, Kristoffersen DT, Laake B, Simonsen S, Tofte AJ, Lundby B. Iodixanol in cardioangiography in patients with coronary artery disease. Tolerability, cardiac and renal effects. Acta Radiol 1993; 34: 72–77.
- 26 Andersen PE, Bolstad B, Berg KJ, Justesen P, Thayssen P, Kloster YF. Iodixanol and ioxaglate in cardioangiography: a double-blind randomized phase III study. Clin Radiol 1993; 48: 268–272.
- 27 Manninen H, Tahvanainen K, Borch KW, Wallén T, Soimakallio S, Matsi P, Suhonen M. Iodixanol, a new non-ionic, dimeric contrast medium in cardioangiography: a double-masked, parallel comparison with iopromide. Eur Radiol 1995; 5: 364–370.
- 28 Hirshfeld JW, Kussmaul WG, DiBattiste PM. Safety of cardiac angiography with conventional ionic contrast agents. Am J Cardiol 1990; 66: 355–361.
- 29 Bergstra A, van Dijk RB, Hillege HL, Lie KI, Mook GA. Assumed oxygen consumption based on calculation from dye dilution cardiac output: an improved formula. Eur Heart J 1995; 16: 698–703.
- 30 Salem DN, Konstam MA, Isner JM, Bonin JD. Comparison of the electrocardiographic and hemodynamic responses to ionic and nonionic radiocontrast media during left ventriculography. a randomized double-blind study. Am Heart J 1986; 111: 533–536.
- 31 Sullivan ID, Wainwright RJ, Reidy JF, Sowton E. Comparative trial of iohexol 350, a non-ionic contrast medium, with diatrizoate (Urografin 370) in left ventriculography and coronary arteriography. Br Heart J 1984; 51: 643–647.
- 32 Wisneski JA, Gertz EW, Dahlgren M, Muslin A. Comparison of low osmolality ionic (ioxaglate) versus nonionic (iopamidol) contrast media in cardiac angiography. Am J Cardiol 1989, 63: 489–495.
- 33 Scholtz ME, Svatos VJ, Myburgh DP. Comparison between a low-osmolar ionic (ioxaglate) and a low-osmolar non-ionic (iopamidol) contrast agent in cardiac imaging. S Afr Med J 1988; 73: 168–171.
- 34 Buschhaus J, Scharf-Bornhofen E. Iohexol and ioversol in arterial cardiac catheter examinations. Comparative presentation of clinical, electrocardiographical, and hemodynamical data for two nonionic contrast media. Herz Kreisl 1991; 23: 331–336.
- 35 Tani M, Handa S, Noma S, Kojima S, Miyamori R, Miyazaki T, Yoshino H, Ohnishi S, Yamazaki H, Nakamura Y. Changes in left ventricular diastolic function after left ventriculography. A comparison with iopamidol and urografin. Am Heart J 1985; 110: 617–622.
- 36 Slutsky R, Higgins C, Costello D, Hooper W, LeWinter MM. Mechanism of increase in left ventricular end-diastolic pressure after contrast ventriculography in patients with coronary artery disease. Am Heart J 1983; 106: 107–113.
- 37 Mancini GBJ, Atwood JE, Bhargava V, Slutsky RA, Grover M, Higgins CB. Comparative effects of ionic and nonionic contrast materials on indexes of isovolumic contraction and relaxation in humans. Am J Cardiol 1984; 53: 228–233.
- 38 Petersen R, McKay CR, Kawanishi DT, Kotlewski A, Parise K, Niland JC. Double-blind comparison of the clinical, hemodynamic, and electrocardiographic effects of sodium meglumine ioxaglate or iohexol during diagnostic cardiac catheterization. Angiology 1992; 43: 765–780.
- 39 Pugh ND, Sissons GRJ, Ruttley MST, Berg KJ, Nossen JØ, Eide H. Iodixanol in femoral arteriography (phase III). A comparative double-blind parallel trial between iodixanol and iopromide. Clin Radiol 1993; 47: 96–99.
- 40 Pugh ND, Griffith TM, Karlsson JOG. Effects of iodinated contrast media on peripheral blood flow. Acta Radiol 1995; 36(Suppl 399): 155–163.
- 41 Hine AL, Lui D, Dawson P. Contrast media osmolality and plasma volume changes. Acta Radiol Diagn 1985; 26: 753–756.
- 42 Yang SS, Bentivoglio LG, Maranhão V, Goldberg H. From cardiac catheterization to hemodynamic parameters. Philadelphia: F.A. Davis Company; 1988. p 231.